Why it matters: Investors are yet again being asked to further support the company, which needs to raise cash for the fifth time in as many years.
Background: Cannasouth has yet to generate any meaningful revenue since listing on the stock exchange in 2019.
Main players: Cannasouth, Mark Lucas, Greg Misson, Eqalis.
Cannasouth came to NBR with a somewhat unusual invitation last month.
The NZX-listed medicinal cannabis company not only wanted to take us on a tour of its state-of-the-art greenhouse and manufacturing facility north of Hamilton, but its executive director, Greg Misson, was willing to fly us down
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
